Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

LL-37

Cathelicidin, hCAP-18, FALL-39, CAP-18

An antimicrobial peptide of the cathelicidin family that provides innate immune defense by killing pathogens and modulating inflammation and wound healing.

Quick Stats
Studies 2230
Trials 95
Formula C205H340N60O53
Clear All
Utility 1
pubmed Jan 11, 2005

LL-37 enhances adaptive antitumor immune response in a murine model when genetically fused with M-CSFR (J6-1) DNA vaccine.

An. Li-Li LL; Yang. Ying-Hua YH; Ma. Xiao-Tong XT; Lin. Yong-Min YM; Li. Ge G; Song. Yu-Hua YH; Wu....

Scientists attached the immune‑boosting peptide LL‑37 directly to a DNA vaccine targeting a cancer‑related receptor in mice, and this combo sparked stronger antibody and killer‑cell responses and helped the mice live longer after tumor exposure. Simply giving LL‑37 alongside the vaccine didn’t work, showing the fusion is crucial. The work is still early‑stage animal research and not a ready‑to‑use protocol for people.

Utility 1
pubmed Mar 24, 2006

Human cathelicidin LL-37 is a chemoattractant for eosinophils and neutrophils that acts via formyl-peptide receptors.

Tjabringa. G Sandra GS; Ninaber. Dennis K DK; Drijfhout. Jan Wouter JW; Rabe. Klaus F KF; Hiemstra....

The study shows that the natural peptide LL‑37 can pull immune cells called eosinophils and neutrophils into the lungs, which may worsen conditions like asthma and COPD. It works through a specific receptor (FPR) but signals differently than other known attractants. This is mainly a basic science finding, not a new treatment tip.

Utility 1
pubmed Feb 1, 2005

Expression and activity of beta-defensins and LL-37 in the developing human lung.

Starner. Timothy D TD; Agerberth. Birgitta B; Gudmundsson. Gudmundur H GH; McCray. Paul B PB

The study looked at natural antimicrobial proteins in newborn lungs and found that one called HBD‑2 is the main defender, its levels rise with gestational age, and it’s boosted by inflammation but lowered by steroids. Other proteins like LL‑37 weren’t seen in the newborn airway cells.

Utility 1
pubmed Mar 2, 2006

Modulation by LL-37 of the responses of salivary glands to purinergic agonists.

Pochet. Stéphanie S; Tandel. Séverine S; Querriére. Stéphanie S; Tre-Hardy. Mari...

The study shows that the antimicrobial peptide LL‑37 can change how mouse salivary gland cells handle calcium and certain enzymes, but it doesn’t work through the usual P2X7 receptor pathway and the effects were seen only in isolated mouse cells.

Utility 1
pubmed Mar 26, 2008

Increased resistance to cationic antimicrobial peptide LL-37 in methicillin-resistant strains of Staphylococcus aureus.

Ouhara. Kazuhisa K; Komatsuzawa. Hitoshi H; Kawai. Toshihisa T; Nishi. Hiromi H; Fujiwara. Tamaki T;...

The study found that MRSA bacteria are more resistant to the human antimicrobial peptide LL‑37 when they have a higher overall electric charge on their surface. This resistance was not seen with another peptide, hBD3, and was linked to how strongly the bacteria resist methicillin.

Utility 1
pubmed Jun 25, 2008

Expression and secretion of cathelicidin LL-37 in human epithelial cells after infection by Mycobacterium bovis Bacillus Calmette-Guérin.

Méndez-Samperio. Patricia P; Miranda. Elena E; Trejo. Artemisa A

The study shows that exposing lung cells to the BCG vaccine triggers the cells to make more of the natural antimicrobial peptide LL‑37, and that this boost depends on specific cell signaling pathways (MEK1/2 and p38 MAPK). Blocking those pathways or stopping new RNA production stops the increase.

Utility 1
pubmed 2005

Marked reduction of LL-37/hCAP-18, an antimicrobial peptide, in patients with acute myeloid leukemia.

An. Li-Li LL; Ma. Xiao-Tong XT; Yang. Ying-Hua YH; Lin. Yong-Min YM; Song. Yu-Hua YH; Wu. Ke-Fu KF

People with acute myeloid leukemia have far less of the natural antibiotic peptide LL‑37 in their blood cells, which may help explain why they get infections easily. The drop isn’t because the gene is turned off, and typical lab tricks like adding bacterial components or forcing cells to mature don’t bring the peptide back.

Utility 1
pubmed 2006

Preparation of LL-37-grafted titanium surfaces with bactericidal activity.

Gabriel. Matthias M; Nazmi. Kamran K; Veerman. Enno C EC; Nieuw Amerongen. Arie V AV; Zentner. Andre...

Scientists attached the antimicrobial peptide LL‑37 to titanium using a special chemical linker, and the coated metal killed bacteria when they touched it. The method keeps the peptide active, but it needs lab‑grade chemistry and equipment, so it isn’t something you can easily do at home.

Utility 1
pubmed Feb 26, 2005

Interaction of antimicrobial peptides with bacterial polysaccharides from lung pathogens.

Herasimenka. Yury Y; Benincasa. Monica M; Mattiuzzo. Maura M; Cescutti. Paola P; Gennaro. Renato R;...

The study shows that slime‑like sugars made by lung bacteria can stick to the natural antimicrobial peptide LL‑37, weakening its ability to kill bugs. Different bacteria affect LL‑37’s shape and how strongly they bind, but overall the binding can block the peptide’s defense role in the airways.

Utility 1
pubmed Apr 17, 2006

Copy number polymorphisms are not a common feature of innate immune genes.

Linzmeier. Rose M RM; Ganz. Tomas T

The research shows that the gene for the antimicrobial peptide LL‑37 (cathelicidin) is present as a single copy in virtually everyone, meaning there’s no common genetic variation that changes how much of it you can naturally make.

Utility 1
pubmed Dec 1, 2006

Changes of antimicrobial peptide mRNA expression in atopic eczema following phototherapy.

Gambichler. T T; Skrygan. M M; Tomi. N S NS; Altmeyer. P P; Kreuter. A A

A small study looked at how a type of UV light therapy (NB-UVB) changes skin antimicrobial peptide genes in people with atopic eczema. The treatment improved skin scores and altered two peptide genes (hBD‑1 went up, hBD‑2 went down), but it didn’t affect the LL‑37 gene. This suggests that UV therapy can shift some skin defense molecules, but it doesn’t give new ways to use LL‑37 for health or performance.

Utility 1
pubmed Dec 14, 2005

Cathepsin D is present in human eccrine sweat and involved in the postsecretory processing of the antimicrobial peptide DCD-1L.

Baechle. Daniel D; Flad. Thomas T; Cansier. Alexander A; Steffen. Heiko H; Schittek. Birgit B; Tolso...

Researchers found that the enzyme cathepsin D is naturally present and active in human sweat, where it chops up the antimicrobial peptide DCD‑1L into several smaller pieces. One of these new fragments is even better at killing E. coli, while another common sweat peptide, LL‑37, isn’t affected. The work shows how our skin’s own enzymes can fine‑tune its natural defenses, but it doesn’t suggest any new supplement or routine for most biohackers.

Utility 1
pubmed 2005

Interleukin-10 downregulates anti-microbial peptide expression in atopic dermatitis.

Howell. Michael D MD; Novak. Natalija N; Bieber. Thomas T; Pastore. Saveria S; Girolomoni. Giampiero...

The study found that a molecule called IL-10, which is higher in both types of atopic dermatitis skin, suppresses the skin's natural antibiotics like LL‑37, making infections more likely. Blocking IL-10 in lab experiments restored these antimicrobial peptides, showing the deficiency is caused by inflammation rather than a genetic flaw.

Utility 1
pubmed 2005

Antimicrobial peptides in the oral environment: expression and function in health and disease.

Dale. Beverly A BA; Fredericks. L Page LP

The paper explains that tiny proteins like LL‑37 and defensins help keep your mouth healthy by stopping harmful microbes and supporting the good bacteria that live there. It shows that normal oral cells make more of a defensin called hBD‑2 when they sense friendly bacteria, which boosts the mouth’s natural defenses. While interesting, the study doesn’t give any specific tips or dosages for using these peptides in everyday health hacks.

Utility 1
pubmed 2004

Host defense proteins in vernix caseosa and amniotic fluid.

Akinbi. Henry T HT; Narendran. Vivek V; Pass. Amy Kun AK; Markart. Philipp P; Hoath. Steven B SB

The study looked at the natural antimicrobial proteins in the skin coating (vernix) and fluid around a baby before birth and found that the peptide LL‑37 isn’t present there, while other proteins like lysozyme and lactoferrin are. This means LL‑37 isn’t a natural component of these fluids, so the paper doesn’t give new ways to use it for health hacks.

Utility 1
pubmed 2005

Cationic antimicrobial peptides elicit a complex stress response in Bacillus subtilis that involves ECF-type sigma factors and two-component signal transduction systems.

Pietiäinen. Milla M; Gardemeister. Marika M; Mecklin. Maria M; Leskelä. Soile S; Sarvas. M...

The study looked at how the human antimicrobial peptide LL‑37 affects a common soil bacterium, Bacillus subtilis. It found that even low amounts of LL‑37 trigger a bunch of stress‑response genes in the bacteria, turning on several signaling systems that help the microbe cope with the peptide. This is about bacterial biology, not a direct health benefit for people.

Utility 1
pubmed Feb 29, 2008

Immunolocalization of defensins and cathelicidin in human glands of Moll.

Stoeckelhuber. Mechthild M; Messmer. Elisabeth M EM; Schubert. Christoph C; Stoeckelhuber. Beate M B...

The study found that the antimicrobial peptide LL‑37, along with two defensins, is naturally present in the tiny glands at the edge of our eyelids (Moll glands). These proteins likely help protect the eye surface from germs, but the research does not suggest any new ways to use LL‑37 as a supplement or treatment.

Utility 1
pubmed 2004

First line of defense in early human life.

Yoshio. Hiroyuki H; Lagercrantz. Hugo H; Gudmundsson. Gudmundur H GH; Agerberth. Birgitta B

LL-37 is a natural antimicrobial protein that’s already present in newborns – in their skin, immune cells and the protective coating called vernix. It helps fight germs and also signals other parts of the immune system.

Utility 1
pubmed 2003

Expression of LL-37/hCAP-18 gene in human leukemia cells.

Yang. Ying-Hua YH; Zheng. Guo-Guang GG; Li. Ge G; Zhang. Bin B; Song. Yu-Hua YH; Wu. Ke-Fu KF

The study looked at how much of the immune peptide LL‑37 is made in different leukemia cell lines and patient blood cells. It found that while many cells have the LL‑37 gene turned on, only a few actually make the peptide protein, especially in certain leukemia types, which may help explain why these patients get infections easily.